Real-World Healthcare data technology company DarkMatter2BD announces rebranding as MedFuse

HOLMDEL, N.J. - May 24, 2022 - PRLog -- DarkMatter2BD LLC, provider of one of the most complete healthcare databases has announced its rebranding to MedFuse.  The change is effective as of May 23, 2022, along with the new company website at www.medfuse.com .

Launched in 2013, as DarkMatter2BD LLC., the MedFuse branded database has been a source of one of the most comprehensive databases linking real-world claims data and physician demographic and affiliation information in the U.S.  The name MedFuse is about expressing the exponential power of linking synergistic data sets.

"Using the MedFuse name for the company, reinforces our focus of helping life science companies and their partners uncover actionable insights by accessing the power of healthcare data" said Kevin Jones, CEO.

Combining the power of claims databases, practitioner demographics and MedFuse's proprietary KOL mapping which networks doctors from medical school to current day, provides unparalleled insights. Fusing these data assets, MedFuse supports commercial operations via evidence-based insights as well as accelerating clinical trial recruitment.

About MedFuse

MedFuse is a healthcare data technology company creating value for our client-partners by combining one of the most complete real-world healthcare databases with a modern technology platform and tools. MedFuse is led by industry veterans who have been delivering claims data solutions for over 40 years.  MedFuse works with client-partners to leverage our rich data resources to reduce costs, increase revenue and contribute to population health. For more information visit www.medfuse.com or contact media@medfuse.com